| Literature DB >> 17407046 |
Daniel P O'Brien1, Delphine Sauvageot, David Olson, Myrto Schaeffer, Pierre Humblet, Mar Pudjades, Tom Ellman, Rony Zachariah, Elisabeth Szumilin, Line Arnould, Tony Read.
Abstract
A study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86-0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17407046 DOI: 10.1086/513433
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079